Literature DB >> 18760449

Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature.

Qingping Yao1, Roy D Altman, Ernest Brahn.   

Abstract

OBJECTIVES: To demonstrate the clinical spectrum of hypertrophic osteoarthropathy (HOA).
METHODS: We report 2 cases of HOA and performed a computer-assisted search of Medline/PubMed for the medical literature from 1960 to June 2008 using the keywords HOA, periostitis, and clubbing. These were also combined with the text words cancer, rheumatic disease, etiology, pathogenesis, hypothesis, transplant, and treatment. Only the English language literature, with pertinent information, was included.
RESULTS: Our 2 cases include 1 HOA case with clubbing, in a patient with a right to left shunt from cryptogenic cirrhosis and interstitial lung disease, and 1 HOA case without apparent clubbing, in a patient with chronic lung transplant rejection secondary to tobacco smoking and related emphysema. Review of the literature has shown that HOA is associated with a wide variety of disorders, approximately 80% are found with primary or metastatic pulmonary malignancies. Various rheumatic diseases, such as systemic vasculitis, can also be associated with HOA. With respect to the pathogenesis, vascular endothelial growth factor, platelet-derived growth factor, and platelets may play crucial roles. Therapeutically, bisphosphonates, such as pamidronade or octreotide, may be tried to relieve symptoms in refractory cases.
CONCLUSIONS: HOA, especially periostitis without clubbing, may go unrecognized. Involvement of vascular endothelial growth factor, platelet-derived growth factor, and platelets in the pathogenesis of HOA has been postulated and supported by recent data. HOA may present as a partial syndrome without clubbing and about 20% of cases have HOA without detectable malignancy. One of our cases represents the first report of the association of HOA with lung transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18760449     DOI: 10.1016/j.semarthrit.2008.07.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  19 in total

1.  Hypertrophic osteoarthropathy in a child due to thoracic Hodgkin's disease.

Authors:  Eleni E Drakonaki; K M Bradley; Z A Khan; C Patel; D J Wilson
Journal:  Skeletal Radiol       Date:  2011-11-18       Impact factor: 2.199

2.  [Bronchial carcinoma and knee pain. Secondary hypertrophic osteoarthropathy].

Authors:  A Baranowski; M Hansen
Journal:  Unfallchirurg       Date:  2013-08       Impact factor: 1.000

Review 3.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

Review 4.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Hypertrophic osteoarthropathy in patient with Crohn's disease: a case report.

Authors:  Sung-Min Rhee; Ki Jeong Park; Yong-Chan Ha
Journal:  J Bone Metab       Date:  2014-05-31

6.  Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

Authors:  Sebastian G Bernardo; Jason J Emer; Mark E Burnett; Marsha Gordon
Journal:  J Clin Aesthet Dermatol       Date:  2012-09

Review 7.  Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.

Authors:  Lina Chen; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

Review 8.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy.

Authors:  Sheila Nguyen; Mehrnaz Hojjati
Journal:  Clin Rheumatol       Date:  2010-10-09       Impact factor: 2.980

9.  Clinical Course of Hypertrophic Pulmonary Osteoarthropathy in a Patient Receiving Immune Checkpoint Inhibitor Therapy.

Authors:  Andrew C Johns; Chad Sorenson; Alan Rogers; Julia L Agne; Desmond M D'Souza; Jishu K Das; Majd Issa; Gina Perna; Terence M Williams; Alexa Meara; Trevor Kitchin; Karl E Haglund; Dwight H Owen
Journal:  Clin Lung Cancer       Date:  2020-01-27       Impact factor: 4.785

10.  Paraneoplastic hypertrophic osteopathy in 30 dogs.

Authors:  S S Withers; E G Johnson; W T N Culp; C O Rodriguez; K A Skorupski; R B Rebhun
Journal:  Vet Comp Oncol       Date:  2013-03-14       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.